Introduction

The superiority of dynamic indices to predict fluid responsiveness compared to static measurements of cardiac preload is widely accepted [1]. Pulse pressure variation, stroke volume variation and surrogate indexes, caused by cyclic changes in left ventricular stroke volume during positive pressure ventilation, have been extensively studied and recognized to assist in decision-making to administrate fluids in hemodynamic unstable patients. However, these parameters have been shown to be reliable predictors of preload-dependence only on deeply sedated patients fully adapted to mechanical ventilation without any spontaneous respiratory effort [2]. Furthermore, predictive value of dynamic parameters in spontaneously breathing patients seems to be inferior to static values of cardiac filling pressures [3].

Passive leg raising maneuver, challenging the cardiovascular system to a reversible and transient fluid challenge [4], has been described as a feasible assessment of fluid responsiveness in a broader population, including patients with cardiac arrhythmias or spontaneous respiratory movements [5]. Nevertheless, this test requires a fast-response device, like esophageal Doppler [5] or transthoracic echocardiography [6], to detect brief hemodynamic changes during the sudden increase in preload due to passive leg raising [7].

The arterial pressure response to the Valsalva maneuver (VM), sustaining a forced expiratory effort against a closed glottis, has been used for decades by cardiologists in the clinical evaluation of patients with congestive heart failure [8, 9] and proposed as a useful and easily applicable tool to detect high ventricular filling pressures [10, 11]. Although cardiovascular changes during the VM are complex, involving both mechanical and neurohormonal factors [12], sudden increases in intrathoracic pressure (ITP) during strain seem to compress cardiac chambers [13], preventing venous emptying to the heart and reducing telediastolic volumes [14]. Since the VM abruptly impairs venous return raising ITP [15], according to the Frank-Starling relationship, patients with both ventricles operating in the ascending part of the cardiac function curve should decrease stroke volume and hence arterial pulse pressure, because of a reduced preload. Whereas patients in the flat portion of the cardiac function curve should not exhibit any significant decrease in stroke volume due to an acute fall in venous return during the strain period. Thus, in this regard, VM could be used as an easy and reversible test to evaluate the preload-dependence condition of a patient.

Therefore, we designed this study to assess the usefulness of arterial pressure changes during a VM to predict fluid responsiveness in spontaneously breathing patients.

Materials and methods

After approval by the institutional Ethics Committee of the hospital, 30 consecutive patients admitted to the multidisciplinary intensive care unit of the Hospital of Jerez were included from July to December 2007. Informed consent was obtained from all patients after inclusion. An additional description of materials and methods can be found in the Electronic Supplementary Material (ESM).

Patient selection

Inclusion criteria were patients with spontaneous breathing without any mechanical ventilation support, who were equipped with an invasive radial arterial catheter as part of standard clinical care and for whom the decision to give fluids was taken because the presence of hypotension, oliguria or tachycardia. Patients were excluded if they had arrhythmia, history of syncope, lack of cooperation to perform the VM or to achieve at least 20 cmH2O of airway pressure.

Cardiac output measurements

A FloTrac™ sensor (Edwards Lifesciences LLC, Irvine, CA, USA) was connected to the arterial line and attached to the Vigileo™ monitor, software version 1.07 (Edwards Lifescience LLC, Irvine, CA, USA). Cardiac output and stroke volume values were averaged as the mean of three consecutive measurements.

The Valsalva maneuver, arterial pressure responses and Valsalva parameters of fluid responsiveness

All patients received a brief training to make them familiar in the performance of the VM. The VM was performed in supine position and consisted of a forced expiration after a normal inspiration through a closed mouthpiece connected to a disposable spirometry transducer (Datex-Ohmeda, Helsinki, Finland). Patients were encouraged to maintain a nearly constant pressure level of 30 cmH2O for 10 s, with the assistance of a pressure marker displayed on the bedside monitor, and then to promptly release the strain and resume normal quiet breathing. A cut-off of 20 cmH2O of airway pressure was selected to ensure an effective decrease on venous return and cardiac preload, since this seems to be the minimum pressure level required to produce a significant decrease in arterial pulse pressure in normal subjects [14].

Arterial responses to the Valsalva maneuver

The normal blood pressure response to the VM, including appropriate responses in heart rate and arterial pressure waveform, provides reliable information about the integrity of the heart function and autonomic reflexes of the cardiovascular system [16]. Traditionally, this response shows four well-defined phases and a typical sinusoidal pattern (Fig. 1) [17]. On the other hand, abnormal arterial pressure response or “square-wave response” to the VM (Fig. 2) [18] has been typically described in patients with severe congestive cardiac failure [8, 9] and has also been related to high left ventricular filling pressures [10, 11] and elevated natriuretic peptides [12].

Fig. 1
figure 1

Normal arterial pressure response during the Valsalva maneuver is characterized by a sinusoidal pattern due to a fall in arterial pressure during phase 2 and overshot during phase 4

Fig. 2
figure 2

Abnormal arterial response is characterized by absence of decreased pulse pressure during phase 2, producing the typical square wave pattern

Valsalva parameters of fluid responsiveness

Since changes in venous return due to the VM were produced mainly during its initial stages (early phase 2), we defined Valsalva pulse pressure variation (∆VPP) as the percent variation between the highest pulse pressure during phase 1 (PPmaxphase1) and the lowest pulse pressure during phase 2 (PPminphase2): ∆VPP (%) = 100 × (PPmaxphase1 − PPminphase2)/[(PPmaxphase1 + PPminphase2)/2]. Similarly, Valsalva systolic pressure variation (∆VSP) was calculated.

Study protocol

Supportive therapies and vasopressors, if present, remained unchanged throughout the study. A first set of hemodynamic measurements was obtained at baseline and the VM was performed immediately after that. Central venous pressure (CVP), invasive arterial pressure and airway pressure were continuously recorded on a personal computer during the whole study time. Volume expansion (VE) consisted of 500 ml of synthetic colloid (Voluven®, hydroxyethylstarch 6%; Fresenius, Bad Homburg, Germany) infused over 30 min. New measurements were obtained after VE and a post-infusion VM was performed.

Statistical analysis

Results are expressed as mean ± SD unless otherwise stated. All data were normally distributed as tested by means of a Kolmogorov–Smirnov test. Patients were classified according to the stroke volume index (SVi) increase after VE in responders (SVi ≥ 15%) and nonresponders (SVi < 15%), according to previous studies references [19, 20].

Hemodynamic and respiratory variables were compared between responders and nonresponders using an independent samples t test, and before and after VE using a paired Student′s t test. The relationships between variables were analyzed using a linear regression method. The area under the receiver operating characteristic (ROC) curves for ∆VPP, ∆VSP, PPmaxphase1, PPminphase2, CVP and SVi according to fluid expansion response were calculated and compared using the Hanley–McNeil test. ROC curves are presented as area ± SE.

A P value <0.05 was considered statistically significant. Statistical analyses were performed using MedCalc for Windows, version 9.4.2.0 (MedCalc Software, Mariakerke, Belgium).

Results

Thirty patients (19 nonresponders and 11 responders) were prospectively included. The main characteristics are summarized in Table 1. One patient was unable to maintain the expiratory pressure above 20 cmH2O and was excluded from the study. Four patients received cathecolamines during the study period: dobutamine (5 μg Kg−1 min−1) associated to norepinephrine (n = 2), and norepinephrine alone (n = 2). Mean norepinephrine dose was 0.46 ± 0.34 μg Kg−1 min−1. All the patients survived at discharge of ICU.

Table 1 Characteristics and demographics data of study population (= 30)

Hemodynamic response to volume expansion

Hemodynamic parameters before and after VE are given in Table 2. SVi increased by 19.5 ± 4% (from 15.2 to 25.4%) in responders, and by 3 ± 9% (from −17.7 to 14.1%) in nonresponders. Cardiac index increased by 16.7 ± 10% (from −0.04 to 39.8) in responders, and by 4.8 ± 9% (from −17.7 to 19.4) in nonresponders. Fluid administration also increased CVP from 5 ± 3 mmHg to 9 ± 4 mmHg (P < 0.0001) in the whole studied population, but did not produce any substantial increase in mean arterial pressure. At baseline, neither CVP cardiac index nor SVi were significantly different between the two groups. Only total systemic vascular resistance was significantly higher in responder patients.

Table 2 Effects of volume expansion (VE) on hemodynamics

Effects of VE on arterial pressure response to a Valsalva maneuver

The effects of the VM on arterial pressure before and after VE are shown in Table 3. Individual values for ∆VPP, ∆VSP and PPminphase2 at baseline are represented in Fig. 3. Although VE significantly decreased ∆VPP, ∆VSP and increased PPminphase2 in both groups, the percentage reduction in ∆VPP and ∆VSP was greater in responders than in nonresponders (45 ± 13 vs. 21 ± 12%, < 0.0001; 23 ± 7 vs. 12 ± 9%, P < 0.01, respectively), whereas PPminphase2 percentage increase induced by VE was greater in responders than in nonresponders (74 ± 30 vs. 32 ± 32%, < 0.01). However, only ∆VPP and ∆VSP remained significantly higher in responders after fluid administration.

Table 3 Effects of the Valsalva maneuver on arterial pressure before and after volume expansion (VE) in 30 spontaneously breathing patients
Fig. 3
figure 3

Distribution of individual values of ΔVPP and ΔVSP (left panel) and PPminphase2 (right panel) before volume expansion. R Responders (stroke volume index increase 15% after volume challenge); NR nonresponders (stroke volume index increase <15% after volume challenge). Points and arrows indicate mean and SD, respectively

A positive linear correlation was found between preinfusion values of ∆VPP and ∆VSP and VE-induced changes in SVi (r 2 = 0.71 and r 2 = 0.60; P < 0.0001, respectively), such that the higher the ∆VPP or ∆VSP, the greater the increase in SVi in response to fluid challenge (Fig. 4). However, a weaker but significant correlation between baseline PPminphase2 and changes in SVi after VE (r 2 = 0.42; < 0.001) was observed. No relationship was found between PPmaxphase1 and preinfusion CVP with changes in SVi after VE.

Fig. 4
figure 4

Linear regression analysis of the relationship between baseline Valsalva pulse pressure variation (ΔVPP) and changes in stroke volume index (ΔSVI) after volume challenge. Dotted curves represent a 95% confidence interval for the regression line

Fluid-induced decreases in ∆VPP and ∆VSP were also correlated with changes in SVi after fluid challenge (r 2 = 0.56 and r 2 = 0.44; P < 0.0001 and P < 0.001, respectively). PPminphase2 increase after VE also correlated with SVi increase (r 2 = 0.54, < 0.0001; Fig. 5).

Fig. 5
figure 5

Linear regression analysis of the relationship between changes induced by volume infusion in Valsalva pulse pressure variation (ΔVPP) and VE-induced changes in stroke volume index (ΔSVI). Dotted curves represent a 95% confidence interval for the regression line

A threshold ∆VPP value of 52% predicted fluid responsiveness with a sensitivity of 91% and a specificity of 95% (positive and negative predictive values were 91 and 95%, respectively), whereas predictive values for ∆VSP and PPminphase2 were lower: a sensitivity of 73% and a specificity of 90% for a cut-off value of 30% for ∆VSP, and a sensitivity of 91% and a specificity of 79% for a PPminphase2 value of 45 mmHg, respectively.

The predictive value of the various indices on fluid responsiveness was compared in Fig. 6. The area under the ROC curves for baseline ∆VPP (0.98 ± 0.03; 95% CI: 0.84–0.99) was significantly higher than CVP (0.51 ± 0.11; 95% CI: 0.32–0.70), PPmaxphase1 (0.55 ± 0.11; 95% CI: 0.36–0.73) and SVi (0.65 ± 0.1; 95% CI: 0.45–0.81) before VE (P < 0.001, respectively), but did not differ from ∆VSP (0.90 ± 0.07; 95% CI: 0.73–0.98) and PPminphase2 (0.89 ± 0.06; 95% CI: 0.72–0.97).

Fig. 6
figure 6

Comparison of receiver operating characteristics curves to discriminate responders and nonresponders to fluid expansion. ΔVPP Valsalva pulse pressure variation, ΔVSP Valsalva systolic pressure variation, PPmin phase2 lowest pulse pressure during phase 2 of the Valsalva maneuver, CVP central venous pressure, SVi stroke volume index

Airway pressure during the Valsalva maneuver

Average airway pressure throughout the Valsalva maneuver was not significantly different before and after volume challenge between both responders and nonresponders (Table 4). Average airway pressure was also strongly correlated with the CVP increase during strain before and after fluid administration (r 2 = 0.72 and r 2 = 0.73; < 0.0001, respectively).

Table 4 Average airway pressure during strain (cmH2O)

Discussion

The present study demonstrates that arterial pressure waveform variations induced by a VM reliably predict fluid responsiveness in spontaneously breathing patients. A ΔVPP value of 52% was predictive with a high sensitivity and specificity of an increase by more than 15% in SVi after volume administration in patients with spontaneous respiratory efforts.

In normal individuals, the VM triggers a typical sequence of complex hemodynamic events. Initially, as ITP rises due to the exaggerated expiratory effort, the pressure gradient for venous return diminishes reducing cardiac filling, telediastolic volumes [13, 21] and pooling blood volume from thoracic vessels within splanchnic circulation [15]. The increase in right atrial pressure, the downstream pressure for venous return, along with the external compression of both vena cavae [22], seem to be the main mechanisms for decreased venous emptying to the right heart. Although mean systemic pressure probably increases because of the active contraction of the abdominal muscles [23], the net effect should be a reduced driving pressure to the right ventricle, since right atrial pressure and venous resistance also increased. Moreover, as pulmonary volume remains unchanged during strain, we can assume that transpulmonary pressure, and hence right ventricular afterload, should be unaffected by the VM [24]. Thus, the rise in ITP and how it affects the venous return should explain solely the reduction in cardiac output observed during expiratory effort. On the other hand, increases in ITP improve left ventricular outflow impedance [25], whereas reduced right ventricular telediastolic volume due to impeded venous return increases left ventricular compliance [26]; so, in preload-dependent patients, in whom cardiac output is primary conditioned by venous return [23], the overall result of sustained increase in ITP during initial stages of VM should be a marked decrease in stroke volume and arterial pulse pressure.

By contrast, in non-preload-dependent patients, since venous return is not a limiting factor for cardiac output, the effect of increased ITP and reduced cardiac preload should be attenuated. Moreover, in severe heart failure condition, enhanced left ventricular function (through reduced left ventricular afterload) and increased left ventricular compliance (through ventricular interdependence) will support stroke volume during strain [27] and, despite impaired venous return, pulse pressure should remain unchanged producing the known square-wave response [18, 28].

Thereby, the spectrum of arterial pressure responses observed during a VM, from the normal sinusoidal pattern to the square-wave response, should be a function of the cardiac preload and the slope of the Frank-Starling curve, in which the blood pressure drop during early phase 2 depicts the relationship between them. Therefore, VM could be considered as a reversible and transient test to challenge the preload-dependence of a patient, inducing a sharp decrease in venous return and preload in the opposite way from the passive leg raising maneuver.

Differences observed in Valsalva parameters of fluid responsiveness in our patients should be explained under this physiological interpretation. In the present study we found that a ∆VPP threshold value of 52% offers the optimal sensitivity/specificity ratio to predict fluid responsiveness in spontaneously breathing patients. Interestingly, this value is very close to the 50% stroke volume reduction observed during a VM in normal preload-dependent subjects [29]. We also observed a strong relationship between baseline ∆VPP and SVi increase induced by volume expansion, so arterial changes during VM provided not only a characterization of patients according to their operating state on the cardiac function curve, but also a quantification of their response to a fluid challenge.

VE produced a significant change in arterial pressure response to the VM in our patients. This volume induced change in the arterial waveform pattern was due mainly to a rise in PPminphase2 (which determines a decrease in ∆VPP and ∆VSP, since PPmaxphase1 remained unchanged), probably as a result of an increase in central blood volume that prevents the fall in venous return and cardiac output during strain [15]. These results are in concordance with previous clinical [11, 18, 30] and experimental [31] studies, in which acute manipulations of plasma volume resulted in reciprocal changes in phase 2 pressure drop during the VM. Therefore, hypovolemic induced condition resulted in a more sinusoidal profile, whereas the hypervolemic state, displacing the cardiac operation point rightward to the flat part of the Frank-Starling curve, produced a more similar square pattern.

Even though this is not the first work that relates arterial pressure changes during the VM and the ventricular function curve [28, 32], this study is pioneer in taking advantage of this relationship to predict fluid responsiveness in a group of patients that represents an important percentage of the critically ill population. Although arterial responses to the Valsalva maneuver had been known for several decades [33], its utility as a clinical tool has been consistently dismissed [8].There is an extensive evidence in clinical literature which supports the VM as a feasible bedside assessment of patients with heart failure [8, 9], since the presence of the arterial square wave response strongly suggests that patients operate in the flat portion of the cardiac function curve. Moreover, a consistent correlation between blood pressure changes during VE and left-sided filling pressure has been demonstrated, putting this forward as a reliable estimation of left ventricular invasive pressures in patients with congestive heart failure [10, 11]. In spite of this evidence, its application in clinical practice remains overlooked. Our small contribution to the knowledge of the mechanisms involved in the hemodynamic consequences of the VM and its potential usefulness to predict fluid responsiveness may encourage interest in this physiological maneuver.

Some limitations of this study must be considered. First, arterial response to the VM has been demonstrated to be posture dependent, mainly due to the effects of orthostatic stress on intrathoracic blood volume [34]. To avoid any confounding factor, all the VMs were performed with patients in supine position, so results may vary in postures other than supine. Second, cardiac arrhythmias can give misleading measurements of arterial blood pressure changes during VM, and patients with arrhythmias were excluded from the present study. Therefore, the predictive value of arterial changes during the Valsalva maneuver may be not reliable in the presence of cardiac arrhythmias. Third, most of the studied population was postsurgical patients with suspected hypovolemia but not established shock, so our results should not be extrapolated to other clinical conditions without caution. Fourth, cardiac output was not measured by the reference thermodilution method. Instead we used the FloTrac/Vigileo™ system, a recently introduced device based on an uncalibrated arterial pulse contour analysis, to track hemodynamic changes after volume administration. Although the accuracy of this system of measuring cardiac output has been criticized in some studies [35], a good agreement with the thermodilution technique was found in more recent papers [36]. Moreover, the ability to detect percentage changes in cardiac output following volume expansion seems to be comparable to the standard bolus thermodilution method [37]. Fifth, although patients were trained to perform a standardized VM, encouraging them to maintain a constant pressure of 30 cmH2O, we cannot guarantee a perfect pressure profile in all patients. Thus, some of the observed differences in the arterial pressure during the VM could be related to these discrepancies. However, the average airway pressure of the VM (a measure for the constant level of applied pressure) was not significantly different between both groups before and after fluid administration. Finally, we selected a 15% cut-off increase in SVi to characterize patients as responders to VE according to previous reported references [19, 20]. Since the intraobserver variability in cardiac output measurements has not been calculated in this study, this threshold may be inaccurate. Therefore, further studies on this regard should be performed.

In conclusion, the present study demonstrates that arterial pressure response to a 10-s VM could be a feasible and useful test to predict fluid responsiveness, without needing for any cardiac output monitoring device, in patients with suspected hypovolemia and without mechanical ventilatory support, completing the available tools to detect preload dependency in spontaneously breathing population, as the passive leg raising test.